CTNNB1 and hepatocellular carcinoma: To address these issues, we introduced a variety of HCC-associated AXIN1 mutations as well as activating CTNNB1 mutations in the liver cancer cell line Huh7, HEK293T cells, and mouse liver progenitor organoids.